Titre : Endotoxines

Endotoxines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Endotoxines : Questions médicales les plus fréquentes", "headline": "Endotoxines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Endotoxines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-12", "dateModified": "2025-05-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Endotoxines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Toxines bactériennes", "url": "https://questionsmedicales.fr/mesh/D001427", "about": { "@type": "MedicalCondition", "name": "Toxines bactériennes", "code": { "@type": "MedicalCode", "code": "D001427", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lipopolysaccharides", "alternateName": "Lipopolysaccharides", "url": "https://questionsmedicales.fr/mesh/D008070", "about": { "@type": "MedicalCondition", "name": "Lipopolysaccharides", "code": { "@type": "MedicalCode", "code": "D008070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.329.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lipide A", "alternateName": "Lipid A", "url": "https://questionsmedicales.fr/mesh/D008050", "about": { "@type": "MedicalCondition", "name": "Lipide A", "code": { "@type": "MedicalCode", "code": "D008050", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.329.500.500" } } }, { "@type": "MedicalWebPage", "name": "Antigènes O", "alternateName": "O Antigens", "url": "https://questionsmedicales.fr/mesh/D019081", "about": { "@type": "MedicalCondition", "name": "Antigènes O", "code": { "@type": "MedicalCode", "code": "D019081", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.329.500.600" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Endotoxines", "alternateName": "Endotoxins", "code": { "@type": "MedicalCode", "code": "D004731", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Johannes Reich", "url": "https://questionsmedicales.fr/author/Johannes%20Reich", "affiliation": { "@type": "Organization", "name": "Microcoat Biotechnologie GmbH, Am Neuland 3, 82347 Bernried am Stanberger See, Germany. j.reich@microcoat.de." } }, { "@type": "Person", "name": "Guy C Brown", "url": "https://questionsmedicales.fr/author/Guy%20C%20Brown", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, UK. gcb3@cam.ac.uk." } }, { "@type": "Person", "name": "John A Kellum", "url": "https://questionsmedicales.fr/author/John%20A%20Kellum", "affiliation": { "@type": "Organization", "name": "Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA." } }, { "@type": "Person", "name": "Gary Hannon", "url": "https://questionsmedicales.fr/author/Gary%20Hannon", "affiliation": { "@type": "Organization", "name": "Nanomedicine and Molecular Imaging Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, Dublin, Ireland." } }, { "@type": "Person", "name": "Adriele Prina-Mello", "url": "https://questionsmedicales.fr/author/Adriele%20Prina-Mello", "affiliation": { "@type": "Organization", "name": "Nanomedicine and Molecular Imaging Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, Dublin, Ireland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A case-control study on immunologic markers of patients with vitiligo.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2022.113785" } }, { "@type": "ScholarlyArticle", "name": "Case-Control Study of Long COVID, Sapporo, Japan.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37044126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3201/eid2905.221349" } }, { "@type": "ScholarlyArticle", "name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37016998", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001192" } }, { "@type": "ScholarlyArticle", "name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35875004", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.913897" } }, { "@type": "ScholarlyArticle", "name": "Significance of temperature in antimuscarinic toxicity: a case-control study.", "datePublished": "2022-06-23", "url": "https://questionsmedicales.fr/article/35735006", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/15563650.2022.2088378" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Toxines biologiques", "item": "https://questionsmedicales.fr/mesh/D014118" }, { "@type": "ListItem", "position": 4, "name": "Toxines bactériennes", "item": "https://questionsmedicales.fr/mesh/D001427" }, { "@type": "ListItem", "position": 5, "name": "Endotoxines", "item": "https://questionsmedicales.fr/mesh/D004731" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Endotoxines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Endotoxines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Endotoxines", "description": "Comment diagnostiquer une intoxication par endotoxines ?\nQuels tests sont utilisés pour détecter les endotoxines ?\nQuels signes cliniques indiquent une exposition aux endotoxines ?\nLes endotoxines peuvent-elles être détectées dans le sang ?\nQuel rôle joue la culture bactérienne dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D004731?mesh_terms=Case-Control+Studies&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Endotoxines", "description": "Quels sont les symptômes d'une intoxication par endotoxines ?\nComment les endotoxines affectent-elles le système immunitaire ?\nLes endotoxines causent-elles des douleurs ?\nQuels signes indiquent un choc septique dû aux endotoxines ?\nLes symptômes varient-ils selon l'exposition ?", "url": "https://questionsmedicales.fr/mesh/D004731?mesh_terms=Case-Control+Studies&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Endotoxines", "description": "Comment prévenir l'exposition aux endotoxines ?\nLes vaccins peuvent-ils prévenir les infections à endotoxines ?\nQuelles mesures de sécurité en laboratoire sont nécessaires ?\nLes antibiotiques préventifs sont-ils efficaces ?\nComment réduire le risque d'infections nosocomiales ?", "url": "https://questionsmedicales.fr/mesh/D004731?mesh_terms=Case-Control+Studies&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Endotoxines", "description": "Quel est le traitement principal pour une intoxication par endotoxines ?\nLes corticostéroïdes sont-ils efficaces contre les endotoxines ?\nComment traiter le choc septique causé par des endotoxines ?\nLes antidotes existent-ils pour les endotoxines ?\nQuelle est l'importance de la prise en charge précoce ?", "url": "https://questionsmedicales.fr/mesh/D004731?mesh_terms=Case-Control+Studies&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Endotoxines", "description": "Quelles sont les complications possibles d'une intoxication par endotoxines ?\nComment les endotoxines affectent-elles les organes ?\nLe syndrome de détresse respiratoire est-il lié aux endotoxines ?\nLes endotoxines peuvent-elles causer des dommages neurologiques ?\nQuel est le pronostic après une exposition aux endotoxines ?", "url": "https://questionsmedicales.fr/mesh/D004731?mesh_terms=Case-Control+Studies&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Endotoxines", "description": "Quels sont les principaux facteurs de risque d'intoxication par endotoxines ?\nLes infections bactériennes augmentent-elles le risque d'endotoxines ?\nLes interventions chirurgicales augmentent-elles le risque ?\nLe diabète est-il un facteur de risque pour les endotoxines ?\nLes conditions de vie insalubres augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D004731?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication par endotoxines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, cultures et évaluation clinique." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les endotoxines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Le test de limule et les tests ELISA sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une exposition aux endotoxines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, hypotension et tachycardie sont des signes fréquents." } }, { "@type": "Question", "name": "Les endotoxines peuvent-elles être détectées dans le sang ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests spécifiques peuvent détecter les endotoxines dans le sang." } }, { "@type": "Question", "name": "Quel rôle joue la culture bactérienne dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'identifier la source bactérienne des endotoxines." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication par endotoxines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, frissons, douleurs abdominales et confusion." } }, { "@type": "Question", "name": "Comment les endotoxines affectent-elles le système immunitaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles provoquent une réponse inflammatoire excessive, pouvant mener à un choc." } }, { "@type": "Question", "name": "Les endotoxines causent-elles des douleurs ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des douleurs abdominales et musculaires." } }, { "@type": "Question", "name": "Quels signes indiquent un choc septique dû aux endotoxines ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Hypotension, tachycardie, confusion et peau froide sont des signes clés." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'exposition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux endotoxines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les environnements contaminés et respecter les protocoles d'hygiène." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils prévenir les infections à endotoxines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de vaccin spécifique contre les endotoxines, mais contre certaines bactéries." } }, { "@type": "Question", "name": "Quelles mesures de sécurité en laboratoire sont nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et des procédures de désinfection." } }, { "@type": "Question", "name": "Les antibiotiques préventifs sont-ils efficaces ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être utilisés dans certains cas à risque, mais pas systématiquement." } }, { "@type": "Question", "name": "Comment réduire le risque d'infections nosocomiales ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Améliorer l'hygiène hospitalière et le contrôle des infections est essentiel." } }, { "@type": "Question", "name": "Quel est le traitement principal pour une intoxication par endotoxines ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des antibiotiques et des soins de soutien pour stabiliser le patient." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces contre les endotoxines ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent réduire l'inflammation, mais leur utilisation est controversée." } }, { "@type": "Question", "name": "Comment traiter le choc septique causé par des endotoxines ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement nécessite des fluides intraveineux et des vasopresseurs." } }, { "@type": "Question", "name": "Les antidotes existent-ils pour les endotoxines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Quelle est l'importance de la prise en charge précoce ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Une prise en charge rapide améliore les chances de survie et réduit les complications." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une intoxication par endotoxines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le choc septique, l'insuffisance organique et la mort." } }, { "@type": "Question", "name": "Comment les endotoxines affectent-elles les organes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer une défaillance multi-organique en raison de l'inflammation." } }, { "@type": "Question", "name": "Le syndrome de détresse respiratoire est-il lié aux endotoxines ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inflammation pulmonaire peut entraîner un syndrome de détresse respiratoire." } }, { "@type": "Question", "name": "Les endotoxines peuvent-elles causer des dommages neurologiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des troubles neurologiques en raison de l'inflammation systémique." } }, { "@type": "Question", "name": "Quel est le pronostic après une exposition aux endotoxines ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le pronostic dépend de la rapidité du traitement et de la gravité de l'exposition." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'intoxication par endotoxines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les patients immunodéprimés, les personnes âgées et les hospitalisés sont à risque." } }, { "@type": "Question", "name": "Les infections bactériennes augmentent-elles le risque d'endotoxines ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections par des bactéries Gram-négatives sont un facteur de risque majeur." } }, { "@type": "Question", "name": "Les interventions chirurgicales augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les interventions chirurgicales peuvent exposer à des endotoxines, surtout en cas d'infection." } }, { "@type": "Question", "name": "Le diabète est-il un facteur de risque pour les endotoxines ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut affaiblir le système immunitaire et augmenter le risque d'infections." } }, { "@type": "Question", "name": "Les conditions de vie insalubres augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles favorisent la prolifération bactérienne et l'exposition aux endotoxines." } } ] } ] }

Sources (10000 au total)

Endothelium-biomarkers for postthrombotic syndrome: a case-control study.

The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev... A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus... Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);... The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...

Risk Factors for Postoperative Pneumonia: A Case-Control Study.

Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ... A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch... Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent... Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ... www.chictr.org.cn, identifier: chiCTR2100045986....

Significance of temperature in antimuscarinic toxicity: a case-control study.

Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p... This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (... Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ... Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.

Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden... Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases... Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh... The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...

Anemia and Idiopathic Intracranial Hypertension: A Case-Control Study.

Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r... Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet... One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%... Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...

Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study.

Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs.... Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor... Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant... Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...

Systemic hormone therapy and dementia: A nested case-control and co-twin control study.

The effect of systemic hormone therapy (HT) on dementia risk is unclear. Our aim was to investigate the association between HT and dementia.... This register-based study consists of a nested case-control study and a co-twin control design, which controls for familial confounding, including shared genetics.... Through Danish national registries from 1995 to 2011, we identified: a) 2700 female singletons with incident dementia and 13,492 matched controls; b) 288 female twins with incident dementia and co-twi... The odds ratio (OR) for the association between systemic HT and dementia was 1.05, 95% CI = [0.93-1.19] in singletons and 2.10, 95% CI = [0.99-4.46] in twins. A statistically significant association w... Using Danish nationwide registries and controlling for education and for familial factors in a subsample, systemic HT was found to be associated with increased dementia risk if used before 2003, when ...